Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details)

v3.21.2
Shareholders' Equity (Details) - $ / shares
1 Months Ended 2 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended 12 Months Ended
Jun. 12, 2021
Jun. 11, 2021
Jul. 31, 2021
Jul. 31, 2021
Apr. 30, 2021
Jul. 31, 2020
Apr. 30, 2020
Jun. 11, 2021
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock issued                     4,000,000  
Number of warrants to purchase additional common shares                     705,882  
Common shares authorized                     1,000,000,000  
Preferred shares authorized     10,000,000 10,000,000         10,000,000      
Common stock par value     $ 0.0001 $ 0.0001         $ 0.0001   $ 0.01  
Common stock shares outstanding                     4,000,000  
Financial Designation, Predecessor and Successor [Fixed List] Successor Predecessor Successor Successor Predecessor Predecessor Predecessor Predecessor Successor Predecessor Predecessor Predecessor
Class A Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock issued     133,059,021 133,059,021         133,059,021   3,840,000  
Common shares authorized     375,000,000 375,000,000         375,000,000   800,000,000  
Common stock par value     $ 0.0001 $ 0.0001         $ 0.0001   $ 0.01  
Common stock shares outstanding     133,059,021 133,059,021         133,059,021   3,840,000  
Class B Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock issued                     160,000  
Common shares authorized                     200,000,000  
Common stock shares outstanding                     160,000  
Class C Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common shares authorized     3,840,000 3,840,000         3,840,000